Trials / Conditions / Active Rheumatoid Arthritis

Active Rheumatoid Arthritis

15 registered clinical trials studyying Active Rheumatoid Arthritis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in NCT07409103	Elevara Medicines Limited	Phase 2
Recruiting	Pulse Steroid Injection in Refractory Rheumatoid Arthritis NCT06456489	Sohag University	Phase 3
Completed	Vitamin D Effect in Rheumatoid Arthritis. NCT04472481	Tanta University	Phase 4
Unknown	Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated Wi NCT03346590	University Hospital, Clermont-Ferrand	N/A
Completed	Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis NCT03599986	Eva Pharma	—
Completed	Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA NCT03172325	Cinnagen	Phase 3
Terminated	To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheum NCT02534896	Sun Pharmaceutical Industries Limited	Phase 3
Completed	Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis NCT01961505	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	N/A
Completed	Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Partic NCT02586246	Astellas Pharma Inc	Phase 3
Completed	Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis NCT01008852	Pfizer	Phase 2
Completed	Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis NCT00959036	Ablynx, a Sanofi company	Phase 1 / Phase 2
Completed	Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis NCT00913458	Pfizer	Phase 4
Completed	Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA) NCT00882024	Nuon Therapeutics, Inc.	Phase 2
Completed	A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Metho NCT00420199	Bristol-Myers Squibb	Phase 3
Completed	Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthriti NCT00393471	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3